logo
logo

Transforming the Future of Precision Medicine.

TenSixteen is the first company leveraging somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.

Learn More
— Contact Us— Join the Team

©2022 TenSixteen Bio, Inc.
A Foresite Labs Company

Privacy Preference Center

Privacy Preferences